Clinical Trial Update: Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Methotrexate [Phase 2]

View source ↗

Summary

Phase 2 pharmacogenomics study evaluating methotrexate for psoriasis vulgaris. The current status is not reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Central South University | Conditions: Psoriasis Vulgaris | Phase 2 | Status: UNKNOWN